| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4263565 | Transplantation Proceedings | 2006 | 4 Pages |
Abstract
Our study suggested that expression of the NKG2D ligand, H60, may activate natural killer cells playing a significant role in innate immunity associated with transplantation. The early expression of H60 mRNA on day 3 in the CsA-treated group might relate to the toxicity of CsA. The expression peaked on day 5 and decreased on day 7, possibly induced by CsA. The results suggested that H60 might be a new target for prevention of rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Z. Ye, L. Feng, S. Huang, S. Li, Y. He, Y. Li,